Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E N Liberopoulos

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Current Medical Research and Opinion|February 23, 2008
Colesevelam hydrochloride in clinical practice: a new approach in the treatment of hypercholesterolaemiaM Florentin, E N Liberopoulos, D P Mikhailidis, et al.
Current Drug Targets|February 16, 2006
Preventing type 2 diabetes in high risk patients: an overview of lifestyle and pharmacological measuresE N Liberopoulos, S Tsouli, D P Mikhailidis, et al.
Current Pharmaceutical Design|March 14, 2008
Fibrate-associated adverse effects beyond muscle and liver toxicityM Florentin, E N Liberopoulos, D P Mikhailidis, et al.
Expert Opinion on Pharmacotherapy|June 24, 2008
Sitagliptin in clinical practice: a new approach in the treatment of type 2 diabetesM Florentin, E N Liberopoulos, D P Mikhailidis, et al.
Expert Opinion on Pharmacotherapy|April 22, 2008
Pleiotropic effects of thiazolidinedionesC V Rizos, E N Liberopoulos, D P Mikhailidis, et al.
The American Journal of Cardiology|July 21, 2001
Atorvastatin versus micronized fenofibrate in the treatment of patients with mixed hyperlipoproteinemiaH J Milionis, E T Bairaktari, E N Liberopoulos, et al.
Alimentary Pharmacology & Therapeutics|August 16, 2006
Statins for non-alcoholic fatty liver disease: a new indication?E N Liberopoulos, V G Athyros, M S Elisaf, et al.
Expert Opinion on Drug Safety|February 25, 2009
How safe is the use of thiazolidinediones in clinical practice?C V Rizos, M S Elisaf, D P Mikhailidis, et al.
The Open Cardiovascular Medicine Journal|June 18, 2010
Fenofibrate in primary biliary cirrhosis: a pilot studyE N Liberopoulos, M Florentin, M S Elisaf, et al.
Current Vascular Pharmacology|February 26, 2010
Aliskiren, a direct renin inhibitor, in clinical practice: a new approach in the treatment of hypertensionE Moutzouri, M Florentin, M S Elisaf, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Current Medical Research and Opinion|February 23, 2008
Colesevelam hydrochloride in clinical practice: a new approach in the treatment of hypercholesterolaemiaM Florentin, E N Liberopoulos, D P Mikhailidis, et al.
Current Drug Targets|February 16, 2006
Preventing type 2 diabetes in high risk patients: an overview of lifestyle and pharmacological measuresE N Liberopoulos, S Tsouli, D P Mikhailidis, et al.
Current Pharmaceutical Design|March 14, 2008
Fibrate-associated adverse effects beyond muscle and liver toxicityM Florentin, E N Liberopoulos, D P Mikhailidis, et al.
Expert Opinion on Pharmacotherapy|June 24, 2008
Sitagliptin in clinical practice: a new approach in the treatment of type 2 diabetesM Florentin, E N Liberopoulos, D P Mikhailidis, et al.
Expert Opinion on Pharmacotherapy|April 22, 2008
Pleiotropic effects of thiazolidinedionesC V Rizos, E N Liberopoulos, D P Mikhailidis, et al.
The American Journal of Cardiology|July 21, 2001
Atorvastatin versus micronized fenofibrate in the treatment of patients with mixed hyperlipoproteinemiaH J Milionis, E T Bairaktari, E N Liberopoulos, et al.
Alimentary Pharmacology & Therapeutics|August 16, 2006
Statins for non-alcoholic fatty liver disease: a new indication?E N Liberopoulos, V G Athyros, M S Elisaf, et al.
Expert Opinion on Drug Safety|February 25, 2009
How safe is the use of thiazolidinediones in clinical practice?C V Rizos, M S Elisaf, D P Mikhailidis, et al.
The Open Cardiovascular Medicine Journal|June 18, 2010
Fenofibrate in primary biliary cirrhosis: a pilot studyE N Liberopoulos, M Florentin, M S Elisaf, et al.
Current Vascular Pharmacology|February 26, 2010
Aliskiren, a direct renin inhibitor, in clinical practice: a new approach in the treatment of hypertensionE Moutzouri, M Florentin, M S Elisaf, et al.
Pageof 4